Short answer · Medically reviewed summary · Last updated: 2026-05-08

Sly syndrome, also known as Mucopolysaccharidosis type VII (MPS VII), is a rare, progressive lysosomal storage disorder caused by a deficiency of the enzyme beta-glucuronidase. This deficiency leads to the harmful accumulation of complex sugar molecules called glycosaminoglycans (GAGs) throughout the body, resulting in multisystem health challenges. What causes Sly syndrome? Sly syndrome occurs due to mutations in the GUSB gene.

What is Sly Syndrome

Name: What is Sly Syndrome
Creator: DiseaseMaps Editorial Team
Published: 2016-12-05UTC12:05:55.0000000

What is Sly Syndrome? Plain-language, medically reviewed definition plus the lived reality told by patients.

Sly syndrome, also known as Mucopolysaccharidosis type VII (MPS VII), is a rare, progressive lysosomal storage disorder caused by a deficiency of the enzyme beta-glucuronidase. This deficiency leads to the harmful accumulation of complex sugar molecules called glycosaminoglycans (GAGs) throughout the body, resulting in multisystem health challenges.

What causes Sly syndrome?

Sly syndrome occurs due to mutations in the GUSB gene. Because the body cannot properly break down GAGs, these substances build up in cells, tissues, and organs, eventually causing them to stop working correctly. It is an autosomal recessive condition, meaning an individual must inherit two copies of the mutated gene—one from each parent—to develop the disease.

Which body systems are affected by Sly syndrome?

Because GAGs are found throughout the body, Sly syndrome is systemic. Clinical manifestations are highly variable, ranging from severe cases diagnosed at birth to milder forms that may not appear until adulthood. Common features include:

Skeletal abnormalities: Short stature, joint stiffness, and dysostosis multiplex (malformation of bones).

Organ enlargement: Hepatomegaly (enlarged liver) and splenomegaly (enlarged spleen).

Neurological impact: Developmental delay or intellectual disability in some, but not all, patients.

Physical features: Coarse facial features and potential corneal clouding.

Respiratory and cardiac issues: Airway obstructions and heart valve thickening.

How rare is Sly syndrome?

Sly syndrome is among the rarest forms of mucopolysaccharidosis, with an estimated prevalence of less than 1 in 250,000 live births globally. Due to its extreme rarity and the broad spectrum of symptom severity, it is often underdiagnosed or misdiagnosed in the general population.

What differentiates Sly syndrome from other MPS disorders?

While Sly syndrome shares many clinical features with other MPS types (such as Hurler or Hunter syndromes), the specific enzyme deficiency of beta-glucuronidase is the key diagnostic marker. Unlike some other MPS disorders, Sly syndrome is uniquely characterized by the potential for hydrops fetalis—a serious condition where fluid accumulates in the fetus—which can be a presenting sign in the most severe neonatal cases.

Next steps

Consult a metabolic specialist or geneticist for definitive enzyme assay testing.

Connect with the Sly syndrome community at DiseaseMaps.org to share experiences.

Review clinical trial registries at ClinicalTrials.gov for the latest therapeutic research.

Medical disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.